🇺🇸 Rimegepant 25 MG in United States

Rimegepant 25 MG (rimegepant-25-mg) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Rimegepant 25 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Rimegepant 25 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rimegepant 25 MG in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Rimegepant 25 MG cost in United States?

annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.